메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

국제건선협회연맹(IFPA), 2025 세계 건선의 날 맞아 건선 도미노 효과 중단 촉구

IFPA, 건선과 정신건강의 밀접한 연관성 인식 및 그 파괴적인 파급효과 방지 위한 행동 촉구 스톡홀름, 2025년 10월 25일 -- 전 세계는 매년 10월 29일 '세계 건선의 날(World Psoriasis Day)'을 맞아 전 세계 6000만 명 이상의 건선 질환자와 연대해 건선에 대한 인식을 제고하고 있다. 올해 국제건선협회연맹(International Federation of Psoriasis Associations•IFPA)은 '도미노 효과를 멈추자(Stop the Domino Effect)'는 글로벌 캠페인을 시작한다. IFPA의 '도미노 효과를 멈추자' 캠페인은 정책 결정자, 의료 전문가, 일반 대중에게 건선이 단순한 피부 질환이 아니라 당뇨와 심혈관 질환부터 우울증에 이르기까지 연쇄적인 심각한 건강 문제를 유발하며 삶에 큰 변화를 미치는 심각한 전신 질환임을 인식해줄 것을 촉구한다. 이 캠페인은 따라서 통합적 치료와 조기 개입 및 전 세계적으로 평등한 치료 접근성이 시급히 필요하다는 점을 강조한다. IFPA는 각국 보건 당국에 건선을 국가 비전염성 질환(NCD) 전략에 포함시키고, 환자
- 김갑성 기자
- 2025-10-25 07:00
MindHYVE.ai™ and Prime Institute of Health Sciences (PIHS) Launch Landmark AI Partnership to Transform Education and Healthcare in Pakistan

ISLAMABAD, Oct. 25, 2025 -- MindHYVE.ai™, a global leader in agentic artificial intelligence and adaptive learning technologies, has announced a landmark partnership with the Prime Institute of Health Sciences (PIHS) in Islamabad, marking a defining milestone in Pakistan's AI transformation journey. This collaboration introduces a dual-sector AI deployment—bringing ArthurAI™ to the classrooms and ChironAI™ to the hospitals of PIHS—making it the first institution in Pakistan to integrate artificial intelligence at scale across both education and healthcare. Arthur
- 김갑성 기자
- 2025-10-25 02:18
Beyond Recovery: QUINEAR QN-071A Brings Professional Compression Therapy Home for Holiday Deals

NEW YORK, Oct. 25, 2025 -- When recovery becomes the new performance edge. True progress doesn't happen during exertion — it begins in recovery. For years, QUINEAR has led the evolution of professional-grade compression systems, making clinical technology accessible to everyday athletes. The QN-071A is the embodiment of that mission: a smart, science-driven leg recovery system designed to help your body rebuild stronger — right from home. Inside the Science Built on Professional Sequential Air Compression Technology, the QN-071A features four independent air chambers that
- 김갑성 기자
- 2025-10-25 00:07
Embracing the Gift of Life, Healing Little Hearts Together

[ 메디채널 김갑성 기자 ] Pantai Hospital Kuala Lumpur and Shangri-La Kuala Lumpur Unites Again to Support Children with Congenital Heart Disease for the Second Year KUALA LUMPUR, Malaysia, Oct. 24, 2025 -- In a powerful display of compassion, purpose, and partnership, Pantai Hospital Kuala Lumpur (PHKL) and Shangri-La Kuala Lumpur came together once more for their annual paediatric cardiac charity initiative, "Embracing the Gift of Life, Healing Little Hearts Together." This meaningful event marked the second year of collaboration between two institutions driven by a shared mission
- 김갑성 기자
- 2025-10-24 22:04
A Self-Reliant Future through HPV 9-Valent Vaccine Alliance: INNOVAX details Localization Strategy in Thailand at IPVS 2025

BANGKOK, Oct. 24, 2025 -- On October 23, 2025, Dr. Zhiming (Tiffany) Jiang, General Manager of Wantai Group, and Dr. Huirong (Harry) Pan, General Manager of Xiamen Innovax Biotech Co., Ltd. ("Innovax"), participated in the 37th International Papillomavirus Society (IPVS) Conference in Bangkok, Thailand. They chaired a dedicated symposium titled "A New Era of HPV Vaccines: The Efforts from Developing Country Manufacturers for Global Cervical Cancer Elimination," which sparked lively discussions among attending experts and scholars. Innovax's booth (#09) "Together Again
- 김갑성 기자
- 2025-10-24 20:20
Terumo Interventional Systems Announces Its New OPUSWAVE® Dual Sensor Imaging System and DualView® Imaging Catheter Receive FDA 510(k) Clearance

OPUSWAVE Imaging System combines OFDI and IVUS into a single catheter, providing significant potential to reduce procedural time and costs in treating coronary artery disease DualView imaging catheter offers a 150mm maximum pullback length, a 2.6 Fr. imaging profile, 6 Fr. guide compatibility and a variable pullback speed of up to 40mm/second in dual mode SOMERSET, N.J., Oct. 24, 2025 -- Terumo Interventional Systems (TIS), a division of Terumo Corporation, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its OPUSWAVE® Dual Sensor I
- 김갑성 기자
- 2025-10-24 20:00
The Future of Life Sciences, Omics and AI Examined by Leading Global Genomic Experts

[ 메디채널 김갑성 기자 ] Groundbreaking Human-Centric Genomic Foundation Model Unveiled HANGZHOU, China, Oct. 24, 2025 -- The future of Omics and AI in life sciences is the central theme for more than 100 scientists and guests from 19 countries and regions gathered in Hangzhou, China, for the 20th Annual Meeting of the International Conference on Genomics (ICG-20) this week. Discussions will span global collaboration in omics and AI, cancer genomics, biodiversity and multi-omics of deep-sea organisms, metagenomics and epidemiology, public health and precision medicine, and the transfor
- 김갑성 기자
- 2025-10-24 18:13
Ribo Granted EMA Orphan Drug Designation for siRNA Therapeutic RBD1016 for Hepatitis Delta Virus (HDV) Infection

BEIJING and GOTHENBURG, Sweden, Oct. 24, 2025 -- Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo), today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to RBD1016 for the treatment of Hepatitis D Virus (HDV) infection. The EMA's ODD is assigned to investigational therapies of life-threatening or chronically debilitating rare diseases that affect no more than five in 10,000 individuals in the European Union. The ODD status provides significant regulatory and commercial incentives, thus enabling
- 김갑성 기자
- 2025-10-24 18:12
AXA Garners Seven Awards at The Hong Kong Insurance Awards 2025

HONG KONG, Oct. 24, 2025 -- AXA Hong Kong and Macau ("AXA") received seven accolades at The Hong Kong Insurance Awards 2025, including three winners and four top 3. The awards spanned key areas such as strategic partnerships, product innovation, AI and analytics, digital transformation, ESG and sustainability, corporate social responsibility, and the demonstrated professionalism and industry expertise of our financial consultants. This recognition underscores AXA's continued leadership in innovation and customer-centric excellence across products and services. It also reflects the C
- 김갑성 기자
- 2025-10-24 17:55
Pfizer and BioNTech Receive Health Sciences Authority Approval for SARS-CoV-2 Sublineage LP.8.1-Adapted Monovalent COVID-19 Vaccine in Singapore

The updated COVID-19 vaccine is expected to be available in Singapore at selected polyclinics and private general practitioner (GP) clinics in October 2025 for individuals 6 months of age and older. SINGAPORE, Oct. 24, 2025 -- Pfizer Singapore and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Health Sciences Authority has approved the companies' LP.8.1-adapted monovalent COVID-19 vaccine (COMIRNATY® LP.8.1; COVID-19 Vaccine, mRNA) for use in individuals 6 months of age and older, according to official recommendations*. This marks Singapore a
- 김갑성 기자
- 2025-10-24 17:33

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2025-11-03_MON

2025-11-02_SUN

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 11월 03일 07시 00분